Cellectis S.A.
CLLS· Nasdaq
Quarterly figures for Cellectis S.A., with source filings when available.
8 quarters. Jun 30, 2019 to Jun 30, 2025. USD.
Filing lag not yet established. Fewer than two comparable filings are on file.
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | |||||||||
| Q2 2025 | Jun 30, 2025 | — | |||||||
Cellectis S.A. · CIK 1627281 · Engraved from SEC EDGAR
| — |
| — |
| — |
| $16.73M |
| +107.5% |
| -$0.24 |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q2 2024 | Jun 30, 2024 | — | — | — | — | $8.06M | +4,428.7% | -$0.28 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | — | — | — | — | — | — | — | |
| Q2 2023 | Jun 30, 2023 | — | — | — | — | $178.00K | −86.8% | -$0.20 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q2 2022 | Jun 30, 2022 | — | — | — | — | $1.35M | −87.9% | -$0.42 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q2 2021 | Jun 30, 2021 | — | — | — | — | $11.18M | +285.4% | -$0.88 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q2 2020 | Jun 30, 2020 | — | — | — | — | $2.90M | +151.7% | -$0.76 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q2 2019 | Jun 30, 2019 | — | — | — | — | $1.15M | — | -$0.79 | |